Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Essential thrombocythemia in children.

Y Dror1, A Zipursky, V S Blanchette

  • 1Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.

Journal of Pediatric Hematology/Oncology
|October 19, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Jamaican Haemophilia Registry: Describing the burden of disease.

Haemophilia : the official journal of the World Federation of Hemophilia·2018
Same author

Improved joint health in subjects with severe haemophilia A treated prophylactically with recombinant factor VIII Fc fusion protein.

Haemophilia : the official journal of the World Federation of Hemophilia·2017
Same author

Molecular analysis and genotype-phenotype correlation of Diamond-Blackfan anemia.

Clinical genetics·2017
Same author

Development of a Thai version of the paediatric bleeding assessment tool (Thai paediatric-BAT) suitable for use in children with inherited mucocutaneous bleeding disorders.

Haemophilia : the official journal of the World Federation of Hemophilia·2017
Same author

Describing the quality of life of boys with haemophilia in China: Results of a multicentre study using the CHO-KLAT.

Haemophilia : the official journal of the World Federation of Hemophilia·2017
Same author

Imaging of haemophilic arthropathy in growing joints: pitfalls in ultrasound and MRI.

Haemophilia : the official journal of the World Federation of Hemophilia·2017

Essential thrombocythemia (ET) in children can lead to severe vascular complications, though platelet counts don't always predict risk. Familial cases appear distinct and more benign, highlighting the need for management guidelines.

Area of Science:

  • Pediatric Hematology
  • Oncology
  • Thrombotic Disorders

Background:

  • Essential thrombocythemia (ET) is a rare myeloproliferative neoplasm.
  • Understanding the clinical presentation and outcomes in pediatric ET is crucial for management.

Purpose of the Study:

  • To evaluate the clinical course, laboratory findings, and outcomes of children diagnosed with essential thrombocythemia.
  • To identify factors associated with complications and disease progression in pediatric ET.

Main Methods:

  • A retrospective analysis of 36 children (6 weeks to 18 years) with ET.
  • Combined institutional data with a review of 34 reported cases from English medical literature.

Main Results:

  • Fifteen patients experienced ET-related symptoms, including severe thrombohemorrhagic phenomena in nine.

Related Experiment Videos

  • Abnormalities included large platelets, increased megakaryocytes, and altered platelet aggregation.
  • Symptomatic patients had higher platelet counts, but thrombotic events occurred even with moderate elevations.
  • Leukemia and myelofibrosis were observed in treated patients; fatalities resulted from leukemia or thrombosis.
  • Forty-seven percent of cases were familial, presenting with lower platelet counts and no thrombotic complications.
  • Conclusions:

    • A significant number of children with ET develop severe vascular complications.
    • Platelet counts correlate with complications but are not always predictive.
    • Current treatment indications and optimal management strategies for pediatric ET are unknown, necessitating guideline development.
    • Familial thrombocythemia in children appears to be a distinct entity with a more favorable prognosis.